Pneumococcal carriage in a large Sicilian sample population: impact on the current epidemiological scenario and implications for future vaccination strategies

Front Cell Infect Microbiol. 2024 Dec 2:14:1467320. doi: 10.3389/fcimb.2024.1467320. eCollection 2024.

Abstract

Introduction: Streptococcus pneumoniae is a prevalent and virulent global pathogen, with colonization being considered a precondition for pneumococcal disease. Understanding colonization is critical for gaining insights into transmission dynamics and developing effective interventions. This study aimed to determine the prevalence of nasopharyngeal colonization and serotype distribution in the Sicilian population.

Methods: Observational study randomly selecting samples belonging to Sicilian individuals whose nasopharyngeal swabs were collected between February 1, 2020, and December 31, 2022. Pneumococcal colonization was determined using PCR for the pneumococcal autolysin (LytA) gene, and positive samples were serotyped.

Results: The study sample consisted of 1,196 individuals, with 17.4% testing positive for the LytA gene. Pneumococcal colonization rates fell from birth to 24 years, with a peak in 0-4-year-olds (aOR=6.9; p<0.001). Colonization was higher in colder months, particularly in December (aOR=2.9, p<0.05) and February (aOR=4, p<0.05). Serotypes 22F and 24ABF exhibited strong colonization and an invasive pneumococcal disease (IPD) risk, whereas serotypes 4, 6AB, 9VA, and 13 had high colonization but a low IPD risk. Serotypes 3 and 8 exhibited considerable IPD risk but low colonization.

Conclusion: Our findings provide insights into pneumococcal colonization mechanisms, influencing serotype prevalence, colonization risk variables, and serotype comparisons for colonization and pathogenicity propensity.

Keywords: Streptococcus pneumoniae; carriage; colonization; epidemiology; serotypes.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Carrier State* / epidemiology
  • Carrier State* / microbiology
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • N-Acetylmuramoyl-L-alanine Amidase / genetics
  • Nasopharynx* / microbiology
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Infections* / microbiology
  • Pneumococcal Vaccines / administration & dosage
  • Pneumococcal Vaccines / immunology
  • Prevalence
  • Serogroup*
  • Serotyping
  • Sicily / epidemiology
  • Streptococcus pneumoniae* / classification
  • Streptococcus pneumoniae* / genetics
  • Streptococcus pneumoniae* / isolation & purification
  • Vaccination
  • Young Adult

Substances

  • Pneumococcal Vaccines
  • N-Acetylmuramoyl-L-alanine Amidase

Grants and funding

Funded in part by a research grant awarded under Merck Sharp & Dohme LLC’s Investigator-Initiated Studies Program. The opinions expressed in this report are those of the authors and do not necessarily represent those of Merck Sharp & Dohme LLC.